There are 2789 resources available
362P - Influence of the expression of ABCG2 transporters on the results of photodynamic therapy in malignant gliomas
Presenter: Artemii Rynda
Session: ePoster Display
363P - Clinical significance of telomerase reverse transcriptase (TERT) promoter mutations, telomere length and MGMT promoter methylation status in newly diagnosed and recurrent IDHwildtype glioblastoma (GBM) patients (PTS): A large mono-institutional study
Presenter: Giuseppe Lombardi
Session: ePoster Display
364P - Implementation of a comprehensive streamlined next generation sequencing (NGS) test for glioma including detection of the 1p/19q codeletion
Presenter: Sian Wood
Session: ePoster Display
414P - Does adjuvant chemotherapy compared to surveillance improve recurrence free and overall survival in stage 3 rectal cancer patients?
Presenter: Sola Adeleke
Session: ePoster Display
417P - Liquid biopsy driven anti-EGFR rechallenge in metastatic colorectal cancer
Presenter: Marco Puzzoni
Session: ePoster Display
418P - Upfront primary tumour resection (UPTR) and survival in synchronous metastatic colorectal cancer according to primary tumour location and RAS status: Pooled analysis of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Presenter: Manuel Benavides
Session: ePoster Display
419P - XELOX/XELIRI alternative regimen as first-line treatment of metastatic colorectal cancer (CCRCTO-2: TROT): A phase II study
Presenter: YU HAN
Session: ePoster Display
420P - A single-arm, multicenter, phase II study of anlotinib combined with CAPEOX as first-line treatment in RAS/BRAF wild-type unresectable metastatic colorectal cancer (ALTER-C002)
Presenter: Kefeng Ding
Session: ePoster Display